US drug industry's guidelines on advertising too limited, say criticsBMJ 2005; 331 doi: http://dx.doi.org/10.1136/bmj.331.7514.420-b (Published 18 August 2005) Cite this as: BMJ 2005;331:420
- Bob Burton
In the face of growing support for tighter regulations on advertising directly to consumers, the US drug industry's trade association has released voluntary guidelines of its own.
However, the guidelines fall short of a proposal by the leader of the Republican Senate majority, Bill Frist, for a two year waiting period before any new drug can be advertised directly to consumers. In July Dr …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial